Click for best price
NSAIDs for Dysmenorrhea Market Size, Share 2023
Diclofenac, ibuprofen, ketoprofen, meclofenamate, mefenamic acid, and naproxen are the NSAIDs specifically approved by the US Food and Drug Administration (FDA) for treatment of dysmenorrhea.
This report aims to provide a comprehensive presentation of the global market for NSAIDs for Dysmenorrhea, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NSAIDs for Dysmenorrhea. This report contains market size and forecasts of NSAIDs for Dysmenorrhea in global, including the following market information:
Global NSAIDs for Dysmenorrhea Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global NSAIDs for Dysmenorrhea Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five NSAIDs for Dysmenorrhea companies in 2022 (%)
The global NSAIDs for Dysmenorrhea market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Ibuprofen Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of NSAIDs for Dysmenorrhea include IOLCP, Granules Biocause, Strides Shasun, BASF, SI Group, Hisoar, Pfizer Inc, Teva and Mylan, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the NSAIDs for Dysmenorrhea manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global NSAIDs for Dysmenorrhea Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global NSAIDs for Dysmenorrhea Market Segment Percentages, by Type, 2022 (%)
Ibuprofen
Celecoxib
Ketoprofen
Others
Global NSAIDs for Dysmenorrhea Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global NSAIDs for Dysmenorrhea Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Pharmacy
Other
Global NSAIDs for Dysmenorrhea Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global NSAIDs for Dysmenorrhea Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies NSAIDs for Dysmenorrhea revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies NSAIDs for Dysmenorrhea revenues share in global market, 2022 (%)
Key companies NSAIDs for Dysmenorrhea sales in global market, 2018-2023 (Estimated), (K Units)
Key companies NSAIDs for Dysmenorrhea sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
IOLCP
Granules Biocause
Strides Shasun
BASF
SI Group
Hisoar
Pfizer Inc
Teva
Mylan
Apotex
Lupin
SANOFI-Aventis
Boehringer-Ingelheim
BEC Chemicals
Shandong Xinhua Pharmaceutical
Hengrui Medicine
Hubei Biocause Heilen Pharmaceutical
Zibo Xinhua-PERRIGO Pharmaceutical
Zhejiang Jiuzhou
Hubei Xunda
Outline of Major Chapters:
Chapter 1: Introduces the definition of NSAIDs for Dysmenorrhea, market overview.
Chapter 2: Global NSAIDs for Dysmenorrhea market size in revenue and volume.
Chapter 3: Detailed analysis of NSAIDs for Dysmenorrhea manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of NSAIDs for Dysmenorrhea in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global NSAIDs for Dysmenorrhea capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
NSAIDs for Dysmenorrhea Market Professional Survey, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
125 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 NSAIDs for Dysmenorrhea Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global NSAIDs for Dysmenorrhea Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global NSAIDs for Dysmenorrhea Overall Market Size
2.1 Global NSAIDs for Dysmenorrhea Market Size: 2022 VS 2029
2.2 Global NSAIDs for Dysmenorrhea Revenue, Prospects & Forecasts: 2018-2029
2.3 Global NSAIDs for Dysmenorrhea Sales: 2018-2029
3 Company Landscape
3.1 Top NSAIDs for Dysmenorrhea Players in Global Market
3.2 Top Global NSAIDs for Dysmenorrhea Companies Ranked by Revenue
3.3 Global NSAIDs for Dysmenorrhea Revenue by Companies
3.4 Global NSAIDs for Dysmenorrhea Sales by Companies
3.5 Global NSAIDs for Dysmenorrhea Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 NSAIDs for Dysmenorrhea Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers NSAIDs for Dysmenorrhea Product Type
3.8 Tier 1, Tier 2 and Tier 3 NSAIDs for Dysmenorrhea Players in Global Market
3.8.1 List of Global Tier 1 NSAIDs for Dysmenorrhea Companies
3.8.2 List of Global Tier 2 and Tier 3 NSAIDs for Dysmenorrhea Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global NSAIDs for Dysmenorrhea Market Size Markets, 2022 & 2029
4.1.2 Ibuprofen
4.1.3 Celecoxib
4.1.4 Ketoprofen
4.1.5 Others
4.2 By Type - Global NSAIDs for Dysmenorrhea Revenue & Forecasts
4.2.1 By Type - Global NSAIDs for Dysmenorrhea Revenue, 2018-2023
4.2.2 By Type - Global NSAIDs for Dysmenorrhea Revenue, 2024-2029
4.2.3 By Type - Global NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2029
4.3 By Type - Global NSAIDs for Dysmenorrhea Sales & Forecasts
4.3.1 By Type - Global NSAIDs for Dysmenorrhea Sales, 2018-2023
4.3.2 By Type - Global NSAIDs for Dysmenorrhea Sales, 2024-2029
4.3.3 By Type - Global NSAIDs for Dysmenorrhea Sales Market Share, 2018-2029
4.4 By Type - Global NSAIDs for Dysmenorrhea Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global NSAIDs for Dysmenorrhea Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Pharmacy
5.1.5 Other
5.2 By Application - Global NSAIDs for Dysmenorrhea Revenue & Forecasts
5.2.1 By Application - Global NSAIDs for Dysmenorrhea Revenue, 2018-2023
5.2.2 By Application - Global NSAIDs for Dysmenorrhea Revenue, 2024-2029
5.2.3 By Application - Global NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2029
5.3 By Application - Global NSAIDs for Dysmenorrhea Sales & Forecasts
5.3.1 By Application - Global NSAIDs for Dysmenorrhea Sales, 2018-2023
5.3.2 By Application - Global NSAIDs for Dysmenorrhea Sales, 2024-2029
5.3.3 By Application - Global NSAIDs for Dysmenorrhea Sales Market Share, 2018-2029
5.4 By Application - Global NSAIDs for Dysmenorrhea Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global NSAIDs for Dysmenorrhea Market Size, 2022 & 2029
6.2 By Region - Global NSAIDs for Dysmenorrhea Revenue & Forecasts
6.2.1 By Region - Global NSAIDs for Dysmenorrhea Revenue, 2018-2023
6.2.2 By Region - Global NSAIDs for Dysmenorrhea Revenue, 2024-2029
6.2.3 By Region - Global NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2029
6.3 By Region - Global NSAIDs for Dysmenorrhea Sales & Forecasts
6.3.1 By Region - Global NSAIDs for Dysmenorrhea Sales, 2018-2023
6.3.2 By Region - Global NSAIDs for Dysmenorrhea Sales, 2024-2029
6.3.3 By Region - Global NSAIDs for Dysmenorrhea Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America NSAIDs for Dysmenorrhea Revenue, 2018-2029
6.4.2 By Country - North America NSAIDs for Dysmenorrhea Sales, 2018-2029
6.4.3 US NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.4.4 Canada NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.4.5 Mexico NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe NSAIDs for Dysmenorrhea Revenue, 2018-2029
6.5.2 By Country - Europe NSAIDs for Dysmenorrhea Sales, 2018-2029
6.5.3 Germany NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.5.4 France NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.5.5 U.K. NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.5.6 Italy NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.5.7 Russia NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.5.8 Nordic Countries NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.5.9 Benelux NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia NSAIDs for Dysmenorrhea Revenue, 2018-2029
6.6.2 By Region - Asia NSAIDs for Dysmenorrhea Sales, 2018-2029
6.6.3 China NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.6.4 Japan NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.6.5 South Korea NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.6.6 Southeast Asia NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.6.7 India NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America NSAIDs for Dysmenorrhea Revenue, 2018-2029
6.7.2 By Country - South America NSAIDs for Dysmenorrhea Sales, 2018-2029
6.7.3 Brazil NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.7.4 Argentina NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa NSAIDs for Dysmenorrhea Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa NSAIDs for Dysmenorrhea Sales, 2018-2029
6.8.3 Turkey NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.8.4 Israel NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.8.5 Saudi Arabia NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.8.6 UAE NSAIDs for Dysmenorrhea Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 IOLCP
7.1.1 IOLCP Company Summary
7.1.2 IOLCP Business Overview
7.1.3 IOLCP NSAIDs for Dysmenorrhea Major Product Offerings
7.1.4 IOLCP NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.1.5 IOLCP Key News & Latest Developments
7.2 Granules Biocause
7.2.1 Granules Biocause Company Summary
7.2.2 Granules Biocause Business Overview
7.2.3 Granules Biocause NSAIDs for Dysmenorrhea Major Product Offerings
7.2.4 Granules Biocause NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.2.5 Granules Biocause Key News & Latest Developments
7.3 Strides Shasun
7.3.1 Strides Shasun Company Summary
7.3.2 Strides Shasun Business Overview
7.3.3 Strides Shasun NSAIDs for Dysmenorrhea Major Product Offerings
7.3.4 Strides Shasun NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.3.5 Strides Shasun Key News & Latest Developments
7.4 BASF
7.4.1 BASF Company Summary
7.4.2 BASF Business Overview
7.4.3 BASF NSAIDs for Dysmenorrhea Major Product Offerings
7.4.4 BASF NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.4.5 BASF Key News & Latest Developments
7.5 SI Group
7.5.1 SI Group Company Summary
7.5.2 SI Group Business Overview
7.5.3 SI Group NSAIDs for Dysmenorrhea Major Product Offerings
7.5.4 SI Group NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.5.5 SI Group Key News & Latest Developments
7.6 Hisoar
7.6.1 Hisoar Company Summary
7.6.2 Hisoar Business Overview
7.6.3 Hisoar NSAIDs for Dysmenorrhea Major Product Offerings
7.6.4 Hisoar NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.6.5 Hisoar Key News & Latest Developments
7.7 Pfizer Inc
7.7.1 Pfizer Inc Company Summary
7.7.2 Pfizer Inc Business Overview
7.7.3 Pfizer Inc NSAIDs for Dysmenorrhea Major Product Offerings
7.7.4 Pfizer Inc NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.7.5 Pfizer Inc Key News & Latest Developments
7.8 Teva
7.8.1 Teva Company Summary
7.8.2 Teva Business Overview
7.8.3 Teva NSAIDs for Dysmenorrhea Major Product Offerings
7.8.4 Teva NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.8.5 Teva Key News & Latest Developments
7.9 Mylan
7.9.1 Mylan Company Summary
7.9.2 Mylan Business Overview
7.9.3 Mylan NSAIDs for Dysmenorrhea Major Product Offerings
7.9.4 Mylan NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.9.5 Mylan Key News & Latest Developments
7.10 Apotex
7.10.1 Apotex Company Summary
7.10.2 Apotex Business Overview
7.10.3 Apotex NSAIDs for Dysmenorrhea Major Product Offerings
7.10.4 Apotex NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.10.5 Apotex Key News & Latest Developments
7.11 Lupin
7.11.1 Lupin Company Summary
7.11.2 Lupin NSAIDs for Dysmenorrhea Business Overview
7.11.3 Lupin NSAIDs for Dysmenorrhea Major Product Offerings
7.11.4 Lupin NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.11.5 Lupin Key News & Latest Developments
7.12 SANOFI-Aventis
7.12.1 SANOFI-Aventis Company Summary
7.12.2 SANOFI-Aventis NSAIDs for Dysmenorrhea Business Overview
7.12.3 SANOFI-Aventis NSAIDs for Dysmenorrhea Major Product Offerings
7.12.4 SANOFI-Aventis NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.12.5 SANOFI-Aventis Key News & Latest Developments
7.13 Boehringer-Ingelheim
7.13.1 Boehringer-Ingelheim Company Summary
7.13.2 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Business Overview
7.13.3 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Major Product Offerings
7.13.4 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.13.5 Boehringer-Ingelheim Key News & Latest Developments
7.14 BEC Chemicals
7.14.1 BEC Chemicals Company Summary
7.14.2 BEC Chemicals Business Overview
7.14.3 BEC Chemicals NSAIDs for Dysmenorrhea Major Product Offerings
7.14.4 BEC Chemicals NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.14.5 BEC Chemicals Key News & Latest Developments
7.15 Shandong Xinhua Pharmaceutical
7.15.1 Shandong Xinhua Pharmaceutical Company Summary
7.15.2 Shandong Xinhua Pharmaceutical Business Overview
7.15.3 Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Major Product Offerings
7.15.4 Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.15.5 Shandong Xinhua Pharmaceutical Key News & Latest Developments
7.16 Hengrui Medicine
7.16.1 Hengrui Medicine Company Summary
7.16.2 Hengrui Medicine Business Overview
7.16.3 Hengrui Medicine NSAIDs for Dysmenorrhea Major Product Offerings
7.16.4 Hengrui Medicine NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.16.5 Hengrui Medicine Key News & Latest Developments
7.17 Hubei Biocause Heilen Pharmaceutical
7.17.1 Hubei Biocause Heilen Pharmaceutical Company Summary
7.17.2 Hubei Biocause Heilen Pharmaceutical Business Overview
7.17.3 Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Major Product Offerings
7.17.4 Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.17.5 Hubei Biocause Heilen Pharmaceutical Key News & Latest Developments
7.18 Zibo Xinhua-PERRIGO Pharmaceutical
7.18.1 Zibo Xinhua-PERRIGO Pharmaceutical Company Summary
7.18.2 Zibo Xinhua-PERRIGO Pharmaceutical Business Overview
7.18.3 Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Major Product Offerings
7.18.4 Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.18.5 Zibo Xinhua-PERRIGO Pharmaceutical Key News & Latest Developments
7.19 Zhejiang Jiuzhou
7.19.1 Zhejiang Jiuzhou Company Summary
7.19.2 Zhejiang Jiuzhou Business Overview
7.19.3 Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Major Product Offerings
7.19.4 Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.19.5 Zhejiang Jiuzhou Key News & Latest Developments
7.20 Hubei Xunda
7.20.1 Hubei Xunda Company Summary
7.20.2 Hubei Xunda Business Overview
7.20.3 Hubei Xunda NSAIDs for Dysmenorrhea Major Product Offerings
7.20.4 Hubei Xunda NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.20.5 Hubei Xunda Key News & Latest Developments
8 Global NSAIDs for Dysmenorrhea Production Capacity, Analysis
8.1 Global NSAIDs for Dysmenorrhea Production Capacity, 2018-2029
8.2 NSAIDs for Dysmenorrhea Production Capacity of Key Manufacturers in Global Market
8.3 Global NSAIDs for Dysmenorrhea Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 NSAIDs for Dysmenorrhea Supply Chain Analysis
10.1 NSAIDs for Dysmenorrhea Industry Value Chain
10.2 NSAIDs for Dysmenorrhea Upstream Market
10.3 NSAIDs for Dysmenorrhea Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 NSAIDs for Dysmenorrhea Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of NSAIDs for Dysmenorrhea in Global Market
Table 2. Top NSAIDs for Dysmenorrhea Players in Global Market, Ranking by Revenue (2022)
Table 3. Global NSAIDs for Dysmenorrhea Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global NSAIDs for Dysmenorrhea Revenue Share by Companies, 2018-2023
Table 5. Global NSAIDs for Dysmenorrhea Sales by Companies, (K Units), 2018-2023
Table 6. Global NSAIDs for Dysmenorrhea Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers NSAIDs for Dysmenorrhea Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers NSAIDs for Dysmenorrhea Product Type
Table 9. List of Global Tier 1 NSAIDs for Dysmenorrhea Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 NSAIDs for Dysmenorrhea Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global NSAIDs for Dysmenorrhea Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global NSAIDs for Dysmenorrhea Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global NSAIDs for Dysmenorrhea Sales (K Units), 2018-2023
Table 15. By Type - Global NSAIDs for Dysmenorrhea Sales (K Units), 2024-2029
Table 16. By Application ? Global NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global NSAIDs for Dysmenorrhea Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global NSAIDs for Dysmenorrhea Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global NSAIDs for Dysmenorrhea Sales (K Units), 2018-2023
Table 20. By Application - Global NSAIDs for Dysmenorrhea Sales (K Units), 2024-2029
Table 21. By Region ? Global NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global NSAIDs for Dysmenorrhea Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global NSAIDs for Dysmenorrhea Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global NSAIDs for Dysmenorrhea Sales (K Units), 2018-2023
Table 25. By Region - Global NSAIDs for Dysmenorrhea Sales (K Units), 2024-2029
Table 26. By Country - North America NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America NSAIDs for Dysmenorrhea Sales, (K Units), 2018-2023
Table 29. By Country - North America NSAIDs for Dysmenorrhea Sales, (K Units), 2024-2029
Table 30. By Country - Europe NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe NSAIDs for Dysmenorrhea Sales, (K Units), 2018-2023
Table 33. By Country - Europe NSAIDs for Dysmenorrhea Sales, (K Units), 2024-2029
Table 34. By Region - Asia NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia NSAIDs for Dysmenorrhea Sales, (K Units), 2018-2023
Table 37. By Region - Asia NSAIDs for Dysmenorrhea Sales, (K Units), 2024-2029
Table 38. By Country - South America NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America NSAIDs for Dysmenorrhea Sales, (K Units), 2018-2023
Table 41. By Country - South America NSAIDs for Dysmenorrhea Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa NSAIDs for Dysmenorrhea Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa NSAIDs for Dysmenorrhea Sales, (K Units), 2024-2029
Table 46. IOLCP Company Summary
Table 47. IOLCP NSAIDs for Dysmenorrhea Product Offerings
Table 48. IOLCP NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. IOLCP Key News & Latest Developments
Table 50. Granules Biocause Company Summary
Table 51. Granules Biocause NSAIDs for Dysmenorrhea Product Offerings
Table 52. Granules Biocause NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Granules Biocause Key News & Latest Developments
Table 54. Strides Shasun Company Summary
Table 55. Strides Shasun NSAIDs for Dysmenorrhea Product Offerings
Table 56. Strides Shasun NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Strides Shasun Key News & Latest Developments
Table 58. BASF Company Summary
Table 59. BASF NSAIDs for Dysmenorrhea Product Offerings
Table 60. BASF NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. BASF Key News & Latest Developments
Table 62. SI Group Company Summary
Table 63. SI Group NSAIDs for Dysmenorrhea Product Offerings
Table 64. SI Group NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. SI Group Key News & Latest Developments
Table 66. Hisoar Company Summary
Table 67. Hisoar NSAIDs for Dysmenorrhea Product Offerings
Table 68. Hisoar NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Hisoar Key News & Latest Developments
Table 70. Pfizer Inc Company Summary
Table 71. Pfizer Inc NSAIDs for Dysmenorrhea Product Offerings
Table 72. Pfizer Inc NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Pfizer Inc Key News & Latest Developments
Table 74. Teva Company Summary
Table 75. Teva NSAIDs for Dysmenorrhea Product Offerings
Table 76. Teva NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Teva Key News & Latest Developments
Table 78. Mylan Company Summary
Table 79. Mylan NSAIDs for Dysmenorrhea Product Offerings
Table 80. Mylan NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Mylan Key News & Latest Developments
Table 82. Apotex Company Summary
Table 83. Apotex NSAIDs for Dysmenorrhea Product Offerings
Table 84. Apotex NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Apotex Key News & Latest Developments
Table 86. Lupin Company Summary
Table 87. Lupin NSAIDs for Dysmenorrhea Product Offerings
Table 88. Lupin NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Lupin Key News & Latest Developments
Table 90. SANOFI-Aventis Company Summary
Table 91. SANOFI-Aventis NSAIDs for Dysmenorrhea Product Offerings
Table 92. SANOFI-Aventis NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. SANOFI-Aventis Key News & Latest Developments
Table 94. Boehringer-Ingelheim Company Summary
Table 95. Boehringer-Ingelheim NSAIDs for Dysmenorrhea Product Offerings
Table 96. Boehringer-Ingelheim NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Boehringer-Ingelheim Key News & Latest Developments
Table 98. BEC Chemicals Company Summary
Table 99. BEC Chemicals NSAIDs for Dysmenorrhea Product Offerings
Table 100. BEC Chemicals NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. BEC Chemicals Key News & Latest Developments
Table 102. Shandong Xinhua Pharmaceutical Company Summary
Table 103. Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Product Offerings
Table 104. Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Shandong Xinhua Pharmaceutical Key News & Latest Developments
Table 106. Hengrui Medicine Company Summary
Table 107. Hengrui Medicine NSAIDs for Dysmenorrhea Product Offerings
Table 108. Hengrui Medicine NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Hengrui Medicine Key News & Latest Developments
Table 110. Hubei Biocause Heilen Pharmaceutical Company Summary
Table 111. Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Product Offerings
Table 112. Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Hubei Biocause Heilen Pharmaceutical Key News & Latest Developments
Table 114. Zibo Xinhua-PERRIGO Pharmaceutical Company Summary
Table 115. Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Product Offerings
Table 116. Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Zibo Xinhua-PERRIGO Pharmaceutical Key News & Latest Developments
Table 118. Zhejiang Jiuzhou Company Summary
Table 119. Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Product Offerings
Table 120. Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. Zhejiang Jiuzhou Key News & Latest Developments
Table 122. Hubei Xunda Company Summary
Table 123. Hubei Xunda NSAIDs for Dysmenorrhea Product Offerings
Table 124. Hubei Xunda NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 125. Hubei Xunda Key News & Latest Developments
Table 126. NSAIDs for Dysmenorrhea Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 127. Global NSAIDs for Dysmenorrhea Capacity Market Share of Key Manufacturers, 2021-2023
Table 128. Global NSAIDs for Dysmenorrhea Production by Region, 2018-2023 (K Units)
Table 129. Global NSAIDs for Dysmenorrhea Production by Region, 2024-2029 (K Units)
Table 130. NSAIDs for Dysmenorrhea Market Opportunities & Trends in Global Market
Table 131. NSAIDs for Dysmenorrhea Market Drivers in Global Market
Table 132. NSAIDs for Dysmenorrhea Market Restraints in Global Market
Table 133. NSAIDs for Dysmenorrhea Raw Materials
Table 134. NSAIDs for Dysmenorrhea Raw Materials Suppliers in Global Market
Table 135. Typical NSAIDs for Dysmenorrhea Downstream
Table 136. NSAIDs for Dysmenorrhea Downstream Clients in Global Market
Table 137. NSAIDs for Dysmenorrhea Distributors and Sales Agents in Global Market
List of Figures
Figure 1. NSAIDs for Dysmenorrhea Segment by Type in 2022
Figure 2. NSAIDs for Dysmenorrhea Segment by Application in 2022
Figure 3. Global NSAIDs for Dysmenorrhea Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global NSAIDs for Dysmenorrhea Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global NSAIDs for Dysmenorrhea Revenue, 2018-2029 (US$, Mn)
Figure 7. NSAIDs for Dysmenorrhea Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by NSAIDs for Dysmenorrhea Revenue in 2022
Figure 9. By Type - Global NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2029
Figure 11. By Type - Global NSAIDs for Dysmenorrhea Sales Market Share, 2018-2029
Figure 12. By Type - Global NSAIDs for Dysmenorrhea Price (US$/Unit), 2018-2029
Figure 13. By Application - Global NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2029
Figure 15. By Application - Global NSAIDs for Dysmenorrhea Sales Market Share, 2018-2029
Figure 16. By Application - Global NSAIDs for Dysmenorrhea Price (US$/Unit), 2018-2029
Figure 17. By Region - Global NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global NSAIDs for Dysmenorrhea Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2029
Figure 20. By Region - Global NSAIDs for Dysmenorrhea Sales Market Share, 2018-2029
Figure 21. By Country - North America NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2029
Figure 22. By Country - North America NSAIDs for Dysmenorrhea Sales Market Share, 2018-2029
Figure 23. US NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2029
Figure 24. Canada NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2029
Figure 27. By Country - Europe NSAIDs for Dysmenorrhea Sales Market Share, 2018-2029
Figure 28. Germany NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2029
Figure 29. France NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2029
Figure 31. Italy NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2029
Figure 32. Russia NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2029
Figure 36. By Region - Asia NSAIDs for Dysmenorrhea Sales Market Share, 2018-2029
Figure 37. China NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2029
Figure 38. Japan NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2029
Figure 41. India NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2029
Figure 43. By Country - South America NSAIDs for Dysmenorrhea Sales Market Share, 2018-2029
Figure 44. Brazil NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa NSAIDs for Dysmenorrhea Sales Market Share, 2018-2029
Figure 48. Turkey NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2029
Figure 49. Israel NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2029
Figure 51. UAE NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2029
Figure 52. Global NSAIDs for Dysmenorrhea Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production NSAIDs for Dysmenorrhea by Region, 2022 VS 2029
Figure 54. NSAIDs for Dysmenorrhea Industry Value Chain
Figure 55. Marketing Channels
